| SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
2.377 |
Evidence |
|
| IRF4 |
IRF4, MUM1: Interferon regulatory factor 4 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.377 |
Evidence |
|
| NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
TAX1BP3 |
TAX1BP3, TIP1: Tax1-binding protein 3 |
2.377 |
Evidence |
|
| RIN1 |
RIN1: Ras and Rab interactor 1 |
DIP13B |
APPL2, DIP13B: DCC-interacting protein 13-beta |
2.377 |
Evidence |
|
| RND3 |
RND3, ARHE, RHO8, RHOE: Rho-related GTP-binding protein RhoE precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
2.377 |
Evidence |
|
| CDH15 |
CDH15, CDH14, CDH3: Cadherin-15 precursor |
DSG2 |
DSG2: Desmoglein-2 precursor |
2.377 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
DAPK2 |
DAPK2: Death-associated protein kinase 2 |
2.377 |
Evidence |
|
| UTRN |
UTRN, DMDL: Utrophin |
DRP2 |
DRP2: Dystrophin-related protein 2 |
2.377 |
Evidence |
O
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
CAMK2A |
CAMK2A, CAMKA, KIAA0968: Calcium/calmodulin-dependent protein kinase type II alp |
2.377 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
DSC3 |
DSC3, DSC4: Desmocollin-3 precursor |
2.377 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
GPR3 |
GPR3, ACCA: Probable G-protein coupled receptor 3 |
2.377 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
LDLRAP1 |
LDLRAP1, ARH: Low density lipoprotein receptor adapter protein 1 |
2.377 |
Evidence |
|
| CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
CDH8 |
CDH8: Cadherin-8 precursor |
2.377 |
Evidence |
|
| SKI |
SKI: Ski oncogene |
IRF3 |
IRF3: Interferon regulatory factor 3 |
2.377 |
Evidence |
|
| SKI |
SKI: Ski oncogene |
FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
2.377 |
Evidence |
|
| RALA |
RALA, RAL: Ras-related protein Ral-A precursor |
MYO10 |
MYO10: Myosin-X |
2.377 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
PAX5 |
PAX5: Paired box protein Pax-5 |
2.377 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
KLK14 |
KLK14, KLKL6: Kallikrein-14 precursor |
2.377 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
RHOQ |
RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor |
2.377 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
KLK14 |
KLK14, KLKL6: Kallikrein-14 precursor |
2.377 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
MAP2K7 |
MAP2K7, JNKK2, MEK7, MKK7, PRKMK7: Dual specificity mitogen-activated protein ki |
2.377 |
Evidence |
|
| HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.377 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
2.377 |
Evidence |
|
| EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
NR4A1 |
CDNA FLJ16818 fis, clone TRACH1000193, highly similar to Orphan nuclear receptor |
2.377 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
2.377 |
Evidence |
|